Dr Elisabete Weiderpass (views are my own) retweetledi
Dr Elisabete Weiderpass (views are my own)
1.7K posts

Dr Elisabete Weiderpass (views are my own)
@IARC_DIR
Director, International Agency for Research on Cancer @IARCWHO
IARC Katılım Haziran 2016
248 Takip Edilen1.7K Takipçiler
Dr Elisabete Weiderpass (views are my own) retweetledi

A solid review of how food additives common in UPFs impact gut health—especially their role in intestinal inflammation. Timely in highlighting the need for broader changes in food safety policy.
faseb.onlinelibrary.wiley.com/doi/10.1096/fj…

English
Dr Elisabete Weiderpass (views are my own) retweetledi

It is with deep sorrow that IARC announces the passing of Professor Pierre Hainaut, former head of our Molecular Carcinogenesis Unit.
He will be remembered not only for his brilliant mind but also for the profoundly human spirit behind the science.
iarc.who.int/news-events/pi…

English
Dr Elisabete Weiderpass (views are my own) retweetledi

The end of an era in public health / prevention/ early detection of cancer. Truly a giant in the field, and one of the most humble, kindest people I've met. He will be missed
@IARCWHO @IARC_DIR @CancerGridIndia
@WHO iarc.who.int/news-events/dr…

English
Dr Elisabete Weiderpass (views are my own) retweetledi

☀️ Summer stats check-in: Nearly 20M new cancer cases & 10 million cancer deaths occurred worldwide in 2022. By 2050, annual incidence could hit 35M, a 77% increase.
Analysis from @IARCWHO & @AmericanCancer urges targeted, global prevention:
acsjournals.onlinelibrary.wiley.com/doi/full/10.33…
@OncoAlert




English
Dr Elisabete Weiderpass (views are my own) retweetledi

Chronic infection with viral hepatitis kills about 3500 people every day.
#WorldHepatitisDay
IARC & @WHO call for urgent action to dismantle the financial, social & systemic barriers – including stigma – to #hepatitis elimination & #LiverCancer prevention. iarc.who.int/news-events/ia…




English
Dr Elisabete Weiderpass (views are my own) retweetledi

🚨 We're hiring 3 #postdocs at @IARCWHO in Lyon, France!
Join us to work with @hilaryarobbins @Mattias31 @XiaoshuangF & me on #cancer #epidemiology & #prevention.
🧠 Background in epi/biostats
📍 Lyon, France
🔗 Details: iarc.who.int/wp-content/upl…
#epitwitter #CancerResearch
English
Dr Elisabete Weiderpass (views are my own) retweetledi

Resistance Training and Mortality Risk: “This systematic review and meta-analysis provides the strongest evidence to date that resistance training is associated with reduced risk of all-cause, cardiovascular disease, and cancer-specific mortality” ajpmonline.org/article/S0749-…
English
Dr Elisabete Weiderpass (views are my own) retweetledi

IARC & @AmericanCancer launch The #Cancer Atlas, 4th Ed, a landmark publication to shape strategies across the cancer continuum!
The Atlas draws on IARC's work to give an overview of cancer burdens, risk factors, & proven measures for prevention & control iarc.who.int/news-events/ia…

English
Dr Elisabete Weiderpass (views are my own) retweetledi

In a 🆕 video, Dr IARC’s @Lyonpaul Brennan presents the latest findings which may explain why #ColorectalCancer is rapidly 📈 in young adults.
Watch & learn what the team found, how they found it, & what it may mean for cancer prevention & early detection.
youtu.be/MeFREImdV28

YouTube
English
Dr Elisabete Weiderpass (views are my own) retweetledi

Thank you to all the panelist for joining me during this #PressBriefing at @myESMO #ESMOGI25
Highlighting the main hot topics of the conference of its wider spread to the public
🛟Prevention
💊New therapies
🫂Relevance of quality of life
⌚️Digital oncology
#ESMOAmbassadors

English
Dr Elisabete Weiderpass (views are my own) retweetledi

The monograph on #talc⚪️, the 1st monograph in IARC Monographs Volume 136: Talc & Acrylonitrile, now available online.
This monograph was accelerated in response to public health demand.
Full volume expected out in coming months.
Visit the Vol 136 webpage:
publications.iarc.who.int/646

English

@_MichaelBaumann Looking forward to meet you and develop collaborations between IARC and DKFZ !
English

A very warm welcome, indeed! We are looking very much forward working with you on new and more effective Strategien to detect and intercept cancer development as early as possible.
DKFZ@DKFZ
We welcome @SigridCarlsson, who started work as Head of the Division "Clinical Epidemiology of Early Cancer Detection". Her aim is to transform cancer screening through personalized, risk-based strategies utilizing biomarkers, novel imaging technology and AI-driven innovation. 👋
English
Dr Elisabete Weiderpass (views are my own) retweetledi

IARC has evaluated the carcinogenicity of #hepatitis D virus #HDV, human cytomegalovirus (HCMV), & Merkel cell polyomavirus (MCPyV). Outcome is published in a summary article in
@TheLancetOncol.
Full assessment to be published as IARC Monographs📙 Vol 139 iarc.who.int/news-events/ia…

English
Dr Elisabete Weiderpass (views are my own) retweetledi

A new Spanish translation of the User’s Guide to Essential TNM, Guía del Usuario TNM Esencial, is now available from IARC.
This publication presents a simplified system that enables cancer registries to assign #cancer stage at diagnosis.
iarc.who.int/news-events/gu…

English
Dr Elisabete Weiderpass (views are my own) retweetledi

"#LungCancer has the epidemiological fingerprint of a 'screenable' cancer type"
IARC's Dr @hilaryarobbins presented at the #G7Cancer Conference on Poor Prognosis Cancers, organized by @Institut_cancer and NCC Japan in #Paris, with @IARC_Dir & other IARC scientists in attendance.




English
Dr Elisabete Weiderpass (views are my own) retweetledi

Final talk of the #Premeeting by @IARC_DIR #PrevCancer2025 on Global Cancer Burden - research and prevention

English
Dr Elisabete Weiderpass (views are my own) retweetledi
Dr Elisabete Weiderpass (views are my own) retweetledi

A wonderful final keynote talk from @IARC_DIR highlighting the impact of cancer and the real need and opportunity for cancer prevention. A call to action for this engaged audience and beyond! #PrevConf25

English
Dr Elisabete Weiderpass (views are my own) retweetledi

"Predictions indicate that the annual number of 🆕 cases of #cancer will reach 35.3 million by 2050.
That is a 7⃣7⃣% increase over the estimate for 2022.
[...]
The greatest increases are predicted in low-& middle-income countries."
@IARC_Dir Dr Elisabete Weiderpass at #PrevConf25
Giota Mitrou@DrPMitrou
@IARC_DIR giving the final keynote lecture outlining the cancer burden issue @CR_UK @AmericanCancer #PrevConf25 @wcrfint
English


